Breakthroughs and Market Evolution in Breast Cancer
Speakers
Max Nisen
Analyst
Bloomberg Intelligence
Max Nisen is a senior associate equity research analyst specializing in the pharmaceutical and biotechnology sector. Prior to joining Bloomberg Intelligence, Max was the founding health care columnist for Bloomberg Gadfly and later Bloomberg Opinion, where he wrote about the pharmaceutical industry, managed care, policy and public health. Before that, he covered business and financial news at Quartz and Business Insider. Max earned a bachelor’s degree in economics from Pomona College.
Tonia Kefala Stavridi
Disease Specialist
Bloomberg Intelligence
Tonia is a Disease Specialist under the Pharma & Biotech team at Bloomberg Intelligence, with a focus on breast cancer including analysis and curation of clinical data, disease epidemiology and addressable market opportunities. She holds a PhD in Biochemistry and MPhil in Biological Sciences from University of Cambridge as well as a BSc in Biotechnology from Imperial College London.